TY - CHAP AU - Desnick, R. AU - Ioannou, Y. AU - Eng, C. ED - Scriver, C. PY - 2001 DA - 2001// TI - Fabry disease: a-galactosidase A deficiency BT - Metabolic and molecular bases of inherited disease PB - McGraw-Hill CY - New York ID - Desnick2001 ER - TY - STD TI - Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34(3):236-42. ID - ref2 ER - TY - JOUR AU - Lyon, M. F. PY - 1961 DA - 1961// TI - Gene action in the X-chromosome of the mouse (Mus musculus L.) JO - Nature VL - 190 UR - https://doi.org/10.1038/190372a0 DO - 10.1038/190372a0 ID - Lyon1961 ER - TY - STD TI - Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79(1):31-40. ID - ref4 ER - TY - STD TI - Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat. 2009;30(10):1397-405. ID - ref5 ER - TY - STD TI - Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138(4):338-46. ID - ref6 ER - TY - STD TI - Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8(9):539-48. ID - ref7 ER - TY - STD TI - Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat. 2003;21(6):577-81. ID - ref8 ER - TY - STD TI - Lai LW, Whitehair O, Wu MJ, O'Meara M, Lien YH. Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease. Clin Genet. 2003;63(6):476-82. ID - ref9 ER - TY - STD TI - Tanislav C, Kaps M, Rolfs A, Bottcher T, Lackner K, Paschke E, et al. Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study. Eur J Neurol. 2011;18(4):631-6. ID - ref10 ER - TY - STD TI - Bono C, Nuzzo D, Albeggiani G, Zizzo C, Francofonte D, Iemolo F, et al. Genetic screening of Fabry patients with EcoTILLING and HRM technology. BMC Res Notes. 2011;4:323. ID - ref11 ER - TY - STD TI - Pisani A, Imbriaco M, Zizzo C, Albeggiani G, Colomba P, Alessandro R, et al. A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report. BMC Cardiovasc Disord. 2012;12:39. ID - ref12 ER - TY - STD TI - Ferri L, Guido C, la Marca G, Malvagia S, Cavicchi C, Fiumara A, et al. Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene. Clin Genet. 2012;81(3):224-33. ID - ref13 ER - TY - STD TI - Tuttolomondo A, Duro G, Pecoraro R, Simonetta I, Miceli S, Colomba P, et al. A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene. Clin Biochem. 2015;48(1-2):55-62. ID - ref14 ER - TY - STD TI - Oliveira JP, Ferreira S, Barcelo J, Gaspar P, Carvalho F, Sa Miranda MC, et al. Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human alpha-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians. J Inherit Metab Dis. 2008;31 Suppl 2:S247-53. ID - ref15 ER - TY - JOUR AU - Davies, J. P. AU - Winchester, B. G. AU - Malcolm, S. PY - 1993 DA - 1993// TI - Sequence variations in the first exon of alpha-galactosidase A JO - J Med Genet VL - 30 UR - https://doi.org/10.1136/jmg.30.8.658 DO - 10.1136/jmg.30.8.658 ID - Davies1993 ER - TY - STD TI - Bekri S, Enica A, Ghafari T, Plaza G, Champenois I, Choukroun G, et al. Fabry disease in patients with end-stage renal failure: the potential benefits of screening. Nephron Clin Pract. 2005;101(1):c33-8. ID - ref17 ER - TY - STD TI - Mayes JS, Scheerer JB, Sifers RN, Donaldson ML. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Clin Chim Acta. 1981;112(2):247-51. ID - ref18 ER - TY - STD TI - Hsu J, Serrano D, Bhowmick T, Kumar K, Shen Y, Kuo YC, et al. Enhanced endothelial delivery and biochemical effects of alpha-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release. 149. Netherlands: 2010 Elsevier B.V; 2011. p. 323-31. ID - ref19 ER - TY - STD TI - Keslová-Veselíková J, Hůlková H, Dobrovolný R, Asfaw B, Poupetová H, Berná L, et al. Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. Virchows Arch. 2008;452(6):651-65. ID - ref20 ER - TY - CHAP AU - Pfaffl, M. ED - Dorak, T. PY - 2006 DA - 2006// TI - Relative quantification BT - Real-time PCR PB - International University Line CY - La Jolla, CA ID - Pfaffl2006 ER - TY - STD TI - Riancho JA, Vazquez L, Garcia-Perez MA, Sainz J, Olmos JM, Hernandez JL, et al. Association of ACACB polymorphisms with obesity and diabetes. Mol Genet Metab. 2011;104(4):670-6. ID - ref22 ER - TY - STD TI - Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123(3):231-43. ID - ref23 ER - TY - STD TI - Ferreira, S., C. Reguenga, and J.P. Oliveira, The Modulatory Effects of the Polymorphisms in GLA 5'-Untranslated Region Upon Gene Expression Are Cell-Type Specific. JIMD Rep, 2015. ID - ref24 ER - TY - STD TI - Mitobe S, Togawa T, Tsukimura T, Kodama T, Tanaka T, Doi K, et al. Mutant alpha-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level. Mol Genet Metab. 2012;107(3):623-6. ID - ref25 ER - TY - STD TI - Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995;23(23):4878-84. ID - ref26 ER - TY - STD TI - Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan JQ. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet. 2002;70(4):994-1002. ID - ref27 ER - TY - STD TI - Filoni C, Caciotti A, Carraresi L, Donati MA, Mignani R, Parini R, et al. Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. Eur J Hum Genet. 2008;16(11):1311-7. ID - ref28 ER - TY - STD TI - Apelland T, Gude E, Strøm EH, Gullestad L, Eiklid KL, Månsson JE, et al. Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease. Heart. 2014;100(22):1793-8. ID - ref29 ER - TY - STD TI - Oliveira JP, Ferreira S, Reguenga C, Carvalho F, Mansson JE. The g.1170C>T polymorphism of the 5' untranslated region of the human alpha-galactosidase gene is associated with decreased enzyme expression--evidence from a family study. J Inherit Metab Dis. 2008;31 Suppl 2:S405-13. ID - ref30 ER - TY - STD TI - Sadowski CL, Henry RW, Kobayashi R, Hernandez N. The SNAP45 subunit of the small nuclear RNA (snRNA) activating protein complex is required for RNA polymerase II and III snRNA gene transcription and interacts with the TATA box binding protein. Proc Natl Acad Sci U S A. 1996;93(9):4289-93. ID - ref31 ER - TY - JOUR AU - Iwakoshi, N. N. AU - Lee, A. H. AU - Glimcher, L. H. PY - 2003 DA - 2003// TI - The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response JO - Immunol Rev VL - 194 UR - https://doi.org/10.1034/j.1600-065X.2003.00057.x DO - 10.1034/j.1600-065X.2003.00057.x ID - Iwakoshi2003 ER - TY - JOUR AU - Hong, C. S. AU - Park, B. Y. AU - Saint-Jeannet, J. P. PY - 2007 DA - 2007// TI - The function of Dmrt genes in vertebrate development: it is not just about sex JO - Dev Biol VL - 310 UR - https://doi.org/10.1016/j.ydbio.2007.07.035 DO - 10.1016/j.ydbio.2007.07.035 ID - Hong2007 ER - TY - JOUR AU - Robertson, K. D. AU - Wolffe, A. P. PY - 2000 DA - 2000// TI - DNA methylation in health and disease JO - Nat Rev Genet VL - 1 UR - https://doi.org/10.1038/35049533 DO - 10.1038/35049533 ID - Robertson2000 ER - TY - STD TI - Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333(5):288-93. ID - ref35 ER - TY - STD TI - Ishii S, Chang HH, Kawasaki K, Yasuda K, Wu HL, Garman SC, et al. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J. 406. England2007. p. 285-95. ID - ref36 ER - TY - CHAP AU - Winchester, B. AU - Young, E. ED - Mehta, A. ED - Beck, M. ED - Sunder-Plassmann, G. PY - 2006 DA - 2006// TI - Biochemical and genetic diagnosis of Fabry disease BT - Fabry disease: perspectives from 5 years ofFOS PB - Pharmagenesis CY - Oxford ID - Winchester2006 ER - TY - STD TI - Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.  Kidney Int. 64. United States2003. p. 801-7. ID - ref38 ER - TY - STD TI - Touboul D, Roy S, Germain DP, Baillet A, Brion F, Prognon P, et al. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. Anal Bioanal Chem. 2005;382(5):1209-16. ID - ref39 ER - TY - STD TI - Kanekura T, Fukushige T, Kanda A, Tsuyama S, Murata F, Sakuraba H, et al. Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol. 2005;153(3):544-8. ID - ref40 ER - TY - JOUR AU - Fortelius, M. AU - Mattjus, P. PY - 2006 DA - 2006// TI - Galactose oxidase action on galactose containing glycolipids--a fluorescence method JO - Chem Phys Lipids VL - 142 UR - https://doi.org/10.1016/j.chemphyslip.2006.03.007 DO - 10.1016/j.chemphyslip.2006.03.007 ID - Fortelius2006 ER - TY - STD TI - Rozenfeld PA, De Francesco NP, Borrajo GJ, Ceci R, Fossati CA. An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: utility for Fabry disease diagnosis and treatment monitoring.  Clin Chim Acta. 403. Netherlands2009. p. 194-7. ID - ref42 ER - TY - STD TI - Askari H, Kaneski CR, Semino-Mora C, Desai P, Ang A, Kleiner DE, et al. Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch. 2007;451(4):823-34. ID - ref43 ER - TY - STD TI - Namdar M, Gebhard C, Studiger R, Shi Y, Mocharla P, Schmied C, et al. Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.  PLoS One. 7. United States2012. p. e36373. ID - ref44 ER -